scholarly journals Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapies

Transfusion ◽  
2009 ◽  
Vol 49 (4) ◽  
pp. 786-796 ◽  
Author(s):  
William Reed ◽  
Stephen J. Noga ◽  
Adrian P. Gee ◽  
Cliona M. Rooney ◽  
John E. Wagner ◽  
...  
Keyword(s):  
United States ◽  
Research Program ◽  
The United States ◽  
Cellular Therapies ◽  
Contract Research ◽  
Blood Institute ◽  
National Heart ◽  
National Heart Lung

scholarly journals Implementation Research to Address the United States Health Disadvantage: Report of a National Heart, Lung, and Blood Institute Workshop

Global Heart ◽  
2018 ◽  
Vol 13 (2) ◽  
pp. 65 ◽  
Author(s):  
Michael M. Engelgau ◽  
K.M. Venkat Narayan ◽  
Majid Ezzati ◽  
Luis A. Salicrup ◽  
Deshiree Belis ◽  
...  
Keyword(s):  
United States ◽  
Implementation Research ◽  
The United States ◽  
Blood Institute ◽  
National Heart ◽  
National Heart Lung ◽  
Institute Workshop

What Are Healthy Blood Pressures for Children?

PEDIATRICS ◽  
1981 ◽  
Vol 68 (2) ◽  
pp. 268-270
Author(s):  
Forrest H. Adams ◽  
Elliot M. Landaw
Keyword(s):  
United States ◽  
Cardiovascular Diseases ◽  
The United States ◽  
Economic Costs ◽  
Blood Institute ◽  
National Heart ◽  
National Heart Lung ◽  
Blood Pressures ◽  
All Diseases

In his report of March 1977 to the President of the United States,1 Dr Robert Levy, director of the National Heart, Lung, and Blood Institute, pointed out that cardiovascular diseases account for more than half of the deaths and approximately one third of the economic costs of all diseases in the United States. Hypertension is a major contributing factor in these cases, and Levy estimated that at least 27 million people in the United States suffer from it, but many do not know they have it. Thus, hypertension is a common and important disorder in the United States. Crucial to a discussion of the problems of hypertension are the answers to such questions as: what constitutes hypertension in the adult or the child; conversely, what are "healthy" blood pressures for both groups; when does hypertension start; and what are the causes of hypertension?

scholarly journals Perspective: Late-Stage (T4) Translation Research and Implementation Science: The National Heart, Lung, and Blood Institute Strategic Vision

2017 ◽  
Vol 27 (4) ◽  
pp. 367 ◽  
Author(s):  
George A. Mensah ◽  
Cheryl Anne Boyce ◽  
LeShawndra N. Price ◽  
Helena O. Mishoe ◽  
Michael M. Engelgau
Keyword(s):  
Implementation Science ◽  
Late Stage ◽  
Health Research ◽  
The United States ◽  
Global Health Research ◽  
Translation Research ◽  
Blood Institute ◽  
Strategic Vision ◽  
National Heart ◽  
National Heart Lung

<p>In August 2016, the National Heart, Lung, and Blood Institute (NHLBI) released its Strategic Vision for charting a course for research over the next decade. This vision was the culmination of an unprecedented process that engaged diverse stakeholders from across the United States and around the globe. The process resulted in four mission-oriented goals and eight strategic objectives that provide an overall framework for advancing research in heart, lung, and blood diseases and sleep disorders. In this perspective, we address opportunities that NHLBI has identified to advance late-stage (T4) translation research, implementation science, health inequities research, global health research, and related research workforce development. Additionally, we highlight the importance of continued active engagement of the clinical and public health research community and the strategic, transdisciplinary, cross-sector partnerships necessary for advancing research priorities to maximize the population-level outcomes and health impact of scientific discoveries.</p><p><em>Ethn Dis. </em>2017;27(4):367-370; doi:10.18865/ed.27.4.367. </p>

Sign in / Sign up

Export Citation Format

Share Document